1. Home
  2. TIL vs SRI Comparison

TIL vs SRI Comparison

Compare TIL & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • SRI
  • Stock Information
  • Founded
  • TIL 2018
  • SRI 1965
  • Country
  • TIL United States
  • SRI United States
  • Employees
  • TIL N/A
  • SRI N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • SRI Auto Parts:O.E.M.
  • Sector
  • TIL Health Care
  • SRI Consumer Discretionary
  • Exchange
  • TIL Nasdaq
  • SRI Nasdaq
  • Market Cap
  • TIL 171.7M
  • SRI 140.6M
  • IPO Year
  • TIL 2021
  • SRI 1997
  • Fundamental
  • Price
  • TIL $26.95
  • SRI $5.02
  • Analyst Decision
  • TIL Buy
  • SRI Buy
  • Analyst Count
  • TIL 5
  • SRI 2
  • Target Price
  • TIL $119.00
  • SRI $16.00
  • AVG Volume (30 Days)
  • TIL 316.4K
  • SRI 355.8K
  • Earning Date
  • TIL 05-13-2025
  • SRI 04-30-2025
  • Dividend Yield
  • TIL N/A
  • SRI N/A
  • EPS Growth
  • TIL N/A
  • SRI N/A
  • EPS
  • TIL N/A
  • SRI N/A
  • Revenue
  • TIL N/A
  • SRI $887,028,000.00
  • Revenue This Year
  • TIL N/A
  • SRI N/A
  • Revenue Next Year
  • TIL N/A
  • SRI $10.18
  • P/E Ratio
  • TIL N/A
  • SRI N/A
  • Revenue Growth
  • TIL N/A
  • SRI N/A
  • 52 Week Low
  • TIL $9.62
  • SRI $3.54
  • 52 Week High
  • TIL $92.00
  • SRI $18.40
  • Technical
  • Relative Strength Index (RSI)
  • TIL 65.08
  • SRI 57.06
  • Support Level
  • TIL $12.60
  • SRI $4.60
  • Resistance Level
  • TIL $35.28
  • SRI $5.09
  • Average True Range (ATR)
  • TIL 3.84
  • SRI 0.33
  • MACD
  • TIL 1.60
  • SRI -0.01
  • Stochastic Oscillator
  • TIL 63.27
  • SRI 52.53

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

Share on Social Networks: